These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height. Comite F; Cassorla F; Barnes KM; Hench KD; Dwyer A; Skerda MC; Loriaux DL; Cutler GB; Pescovitz OH JAMA; 1986 May; 255(19):2613-6. PubMed ID: 3084811 [TBL] [Abstract][Full Text] [Related]
4. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis. Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027 [TBL] [Abstract][Full Text] [Related]
5. Precocious puberty in children with neurofibromatosis type 1. Habiby R; Silverman B; Listernick R; Charrow J J Pediatr; 1995 Mar; 126(3):364-7. PubMed ID: 7869193 [TBL] [Abstract][Full Text] [Related]
6. Effect of deslorelin dose in the treatment of central precocious puberty. Pescovitz OH; Barnes KM; Cutler GB J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743 [TBL] [Abstract][Full Text] [Related]
7. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629 [TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation. Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. Crowley WF; Comite F; Vale W; Rivier J; Loriaux DL; Cutler GB J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592 [TBL] [Abstract][Full Text] [Related]
10. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome. Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582 [TBL] [Abstract][Full Text] [Related]
11. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. Harris DA; Van Vliet G; Egli CA; Grumbach MM; Kaplan SL; Styne DM; Vainsel M J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035 [TBL] [Abstract][Full Text] [Related]
12. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules. Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759 [TBL] [Abstract][Full Text] [Related]
15. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562 [TBL] [Abstract][Full Text] [Related]
16. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty. Comite F; Pescovitz OH; Rieth KG; Dwyer AJ; Hench K; McNemar A; Loriaux DL; Cutler GB J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587 [TBL] [Abstract][Full Text] [Related]
17. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. Comite F; Cutler GB; Rivier J; Vale WW; Loriaux DL; Crowley WF N Engl J Med; 1981 Dec; 305(26):1546-50. PubMed ID: 6458765 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of leuprolide therapy in children with central precocious puberty. Kappy MS; Stuart T; Perelman A Am J Dis Child; 1988 Oct; 142(10):1061-4. PubMed ID: 3140654 [TBL] [Abstract][Full Text] [Related]
19. Somatomedin-C in accelerated growth of children with precocious puberty. Pescovitz OH; Rosenfeld RG; Hintz RL; Barnes K; Hench K; Comite F; Loriaux DL; Cutler GB J Pediatr; 1985 Jul; 107(1):20-5. PubMed ID: 3891947 [TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. Rosenthal SM; Grumbach MM; Kaplan SL J Clin Endocrinol Metab; 1983 Sep; 57(3):571-9. PubMed ID: 6223935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]